Your session is about to expire
← Back to Search
Behavioral Intervention
Online Mind-Body Wellness Program for Chronic Conditions (EMPOwer Trial)
N/A
Waitlist Available
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Identified diagnosis of one of nine chronic conditions (Heart Failure, PBC, Digestive Disease, Cirrhosis, Cancer survivor, Post-transplant, Women who have experienced a cardiac event, Chronic Kidney Disease), or another general category for physical chronic conditions not captured by these nine
Be older than 18 years old
Must not have
Inability to provide informed written consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a 12-week online program for adults ≥50 with chronic physical conditions to improve mental wellness and reduce anxiety/depression. The program includes mindful movement, breathwork, meditation and more.
Who is the study for?
Adults over 18 with chronic conditions like heart failure, liver cirrhosis, cancer survival, post-transplant recovery or kidney disease can join. They must speak English well enough for surveys and have internet plus a computer or smart device.
What is being tested?
The trial tests an online mind-body wellness program against the same program with added weekly check-ins. It's to see if they help reduce anxiety and depression in people with various chronic illnesses over a 12-week period.
What are the potential side effects?
Since this is a non-invasive mental wellness program involving activities like meditation and breathwork, no significant physical side effects are expected. Participants may experience emotional discomfort when addressing personal health issues.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with a chronic condition like heart failure or cancer.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am unable to sign or understand the consent form.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Hospital Anxiety and Depression Scale (HADS)
Secondary study objectives
Capability, Opportunity, Motivation, Behaviour (COM-B) Survey
EQ-5D-5L
Health Related Quality of Life
+2 moreOther study objectives
Demoralization (Exploratory)
Edmonton Frail Scale (Exploratory)
Fried Frailty (Exploratory)
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Online Program + Weekly Check-insExperimental Treatment2 Interventions
Online program (mindful movement, meditation, breathwork, psychology-based coping skills program) + brief 1-to-1 weekly check-ins with a study team member
Group II: Online ProgramExperimental Treatment1 Intervention
Online program (mindful movement, meditation, breathwork, psychology-based coping skills program)
Group III: Waitlist ControlActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,388 Previous Clinical Trials
26,517,273 Total Patients Enrolled
31 Trials studying Heart Failure
2,877,441 Patients Enrolled for Heart Failure
University of AlbertaLead Sponsor
939 Previous Clinical Trials
433,113 Total Patients Enrolled
28 Trials studying Heart Failure
5,325 Patients Enrolled for Heart Failure
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with a chronic condition like heart failure or cancer.I am 18 years old or older.I am unable to sign or understand the consent form.You have severe mental health issues like uncontrolled schizophrenia, PTSD, or bipolar disorder, unless your doctor or psychologist approves your participation.I am receiving end-of-life care.
Research Study Groups:
This trial has the following groups:- Group 1: Waitlist Control
- Group 2: Online Program
- Group 3: Online Program + Weekly Check-ins
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger